You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 8, February 23, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Alert me on articles by topic

Cocaine and Phenylephrine Eye Drop Test for Parkinson Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: While there is no specific diagnostic test for Parkinson disease (PD), recent studies using iodine 123–metaiodobenzylguanidine (MIBG) have shown that cardiac sympathetic innervation is reduced in patients with PD.1-2 {alpha}-Synuclein aggregations are found in the sympathetic ganglions as well as in the midbrain dopaminergic neurons.3 It is possible that sympathetic innervation to the pupillary dilator muscle in PD is reduced because it is innervated by the cervical sympathetic ganglia. We studied sympathetic dysfunction in the pupils as a possible diagnostic marker of PD by comparing responses to cocaine eye drops and phenylephrine eye drops. Cocaine blocks norepinephrine uptake, and cocaine-induced mydriasis is dependent on the sympathetic nerve terminal density. In contrast, phenylephrine acts directly on the adrenergic receptor to cause mydriasis.

Methods

Participants included patients with PD (according to the criteria of the United Kingdom Parkinson’s Disease Society Brain Bank4), controls (patients reporting symptoms including headache, . . . [Full Text of this Article]

Hideyuki Sawada, MD, PhD; Kentarou Yamakawa, MD; Hodaka Yamakado, MD
Department of Neurology
Kyoto University Hospital
Kyoto, Japan

Ryohei Hosokawa, MD, PhD; Muneo Ohba, MD
Department of Cardiology
Kyoto University Hospital

Kazuaki Miyamoto, MD, PhD
Department of Ophthalmology
Kyoto University Hospital

Takashi Kawamura, MD, PhD
Kyoto University Center for Student Health

Shun Shimohama, MD, PhD
i53367@sakura.kudpc.kyoto-u.ac.jp
Department of Neurology
Kyoto University Hospital







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.